Scientific knowledge map analysis of pain management after spinal cord injury based on CiteSpace
YANG Xiangyu1 ZHOU Binbin2 SU Ting1 MO Qilin1 XIA Weihua1 XIONG Yihe1
1.Graduate School, Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Naning 530000, China;
2.Department of Rehabilitation Medicine, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Naning 530001, China
摘要目的 运用CiteSpace对脊髓损伤后疼痛治疗领域进行科学知识图谱分析。 方法 检索2011年1月至2022年5月中国知网和Web of Science核心合集中关于脊髓损伤后疼痛治疗的文献，应用CiteSpace软件，分别绘制作者、机构、关键词的知识图谱。 结果 共纳中国知网文献348篇，Web of Science核心合集中核心文献1 398篇。国内核心学者主要有李勇杰、倪家骧、胡永生、陶蔚，国外核心学者主要有MICHAEL G FEHLINGS、MARK P JENSEN、BRUCE PARSONS、JAMES W GRAU。贡献量最高的国内机构为广东省工伤康复医院，国外核心机构为迈阿密大学、威斯康星大学、多伦多大学、哈佛大学医学院、得克萨斯农工大学。高频次关键词主要有细胞疗法、干细胞、康复、电针、刺激疗法。关键词突现强度最高的是电针、细胞疗法。 结论 细胞疗法、电针、电刺激依然是最新研究热点，研究热度依然不减，有日益剧增趋势，巴氯芬、肉毒杆菌毒素、中药熏蒸、刺络拔罐近些年临床治疗效果显著，这也许是未来新的研究热点与新趋势之一。
Abstract：Objective To analyze the scientific knowledge map in the field of pain treatment after spinal cord injury use CiteSpace. Methods Literature on pain treatment after spinal cord injury was retrieved from CNKI and Web of Science core collection database from January 2011 to May 2022, CiteSpace software was used to draw the knowledge map of author, institution, and key words. Results A total of 348 literatures on CNKI and 1 398 literatures on Web of Science were included in the core collection. Domestic core scholars mainly include Li Yongjie, Ni Jiaxiang, Hu Yongsheng, and Tao Wei, and the foreign core scholars mainly include MICHAEL G FEHLINGS, MARK P JENSEN, BRUCE PARSONS, and JAMES W GRAU. The largest domestic institution was the Guangdong Industrial Injury Rehabilitation Hospital, while the core foreign institutions were the University of Miami, the University of Wisconsin, the University of Toronto, Harvard Medical School and Texas A&M University. The key words with high frequency were cell therapy, stem cell, rehabilitation, electroacupuncture, stimulation therapy. Keywords electroacupuncture and cell therapy have the highest intensity of emergence. Conclusion Cell therapy, electroacupuncture, and electrical stimulation are still the latest research hotspots, and the research heat is still not decreasing, with an increasing trend. Baclofen, botulinum toxin, traditional Chinese medicine fumigation, acupuncture and cupping have good clinical effects in recent years, which may be one of the new research hotspots and new trends in the future.
[1] Zarco Peri?觡án MJ，Barrera Chacón JM，García Obrero I，et al. Quality of life in patients with spinal cord injury for at least 10years：Importance of secondary health complications[J]. Rehabilitacion （Madr），2022，56（1）：28-38.
[2] Shaw E，Saulino M. Management Strategies for Spinal Cord Injury Pain Updated for the Twenty-First Century [J]. Phys Med Rehabil Clin N Am，2020，31（3）：369-378.
[3] Bresnahan JJ，Scoblionko BR，Zorn D，et al. The demographics of pain after spinal cord injury：a survey of our model system [J]. Spinal Cord Ser Cases，2022，8（1）：14.
[4] Siddall PJ，Middleton JW. Spinal cord injury-induced pain：mechanisms and treatments [J]. Pain Manag，2015，5（6）：493- 507.
[5] Kupfer M，Formal CS. Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain [J]. J Spinal Cord Med，2022，45（2）：163-172.
[6] Attal N. Spinal cord injury pain [J]. Rev Neurol （Paris），2021，177（5）：606-612.
[7] Ahuja CS，Nori S，Tetreault L，et al. Traumatic Spinal Cord Injury-Repair and Regeneration [J]. Neurosurgery，2017，80（3S）：S9-S22.
[8] Ahuja CS，Wilson JR，Nori S，et al. Traumatic spinal cord injury [J]. Nat Rev Dis Primers，2017，3：17018.
[9] Hachem LD，Fehlings MG. Pathophysiology of Spinal Cord Injury [J]. Neurosurg Clin N Am，2021，32（3）：305-313.
[10] Vawda R，Badner A，Hong J，et al. Harnessing the Secretome of Mesenchymal Stromal Cells for Traumatic Spinal Cord Injury：Multicell Comparison and Assessment of In Vivo Efficacy [J]. Stem Cells Dev，2020，29（22）：1429- 1443.
[11] Ahuja CS，Mothe A，Khazaei M，et al. The leading edge：Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury [J]. Stem Cells Transl Med，2020，9（12）：1509-1530.
[12] McIntyre WB，Pieczonka K，Khazaei M，et al. Regenerative replacement of neural cells for treatment of spinal cord injury [J]. Expert Opin Biol Ther，2021，21（11）：1411-1427.
[13] Shibata R，Nagoshi N，Kajikawa K，et al. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury [J]. J Neurotrauma，2022，39（9/10）：667-682.
[14] Amtmann D，Bamer AM，Askew R，et al. Cross-lagged longitudinal analysis of pain intensity and sleep disturbance [J]. Disabil Health|，2020，13（3）：100908.
[15] Alschuler KN，Jensen MP，Sullivan-Singh SJ，et al. The association of age，pain，and fatigue with physical functioning and depressive symptoms in persons with spinal cord injury [J]. J Spinal Cord Med，2013，36（5）：483-491.
[16] Battalio SL，Glette M，Alschuler KN，et al. Anxiety，depression，and function in individuals with chronic physical conditions：A longitudinal analysis [J]. Rehabil Psychol，2018， 63（4）：532-541.
[17] Miró J，Gertz KJ，Carter GT，et al. Pain location and functioning in persons with spinal cord injury [J]. PMR，2014，6（8）：690-697.
[18] de la Vega R，Mendoza ME，Chan JF，et al. Case Study：Cognitive Restructuring Hypnosis for Chronic Pain in a Quadriplegic Patient [J]. Am J Clin Hypn，2019，61（4）：394- 408.
[19] de la Vega R，Molton IR，Miró J，et al. Jensen MP. Changes in perceived social support predict changes in depressive symptoms in adults with physical disability [J]. Disabil Health J，2019，12（2）：214-219.
[20] Parsons B，Fujii K，Nozawa K，et al. The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain [J]. J Pain Res，2019，12：1061-1068.
[21] Sadosky A，Parsons B，Emir B，et al. Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury：an exploratory analysis of pregabalin clinical trials [J]. J Pain Res，2016，9：405-416.
[22] 胡永生，李勇杰，陶蔚，等.运动皮质电刺激术治疗顽固性神经病理性疼痛[J].中国微侵袭神经外科杂志，2013， 18（2）：53-56.
[23] 倪兵，杜涛，胡永生，等.背根神经节电刺激治疗慢性疼痛现状及国产化前景[J].中国疼痛医学杂志，2021，27（11）：810-814.
[24] 倪兵，朱宏伟，杜涛，等.反向放置脊髓电刺激电极治疗脊柱外伤后神经病理性疼痛[J].中国微侵袭神经外科杂志，2021，26（4）：173-174.
[25] 倪家骧.神经病理性疼痛的微创介入治疗[J].中国康复医学杂志，2012，27（7）：671-674.
[26] 王庆勇，杨添淞，屈媛媛，等.针刺对SCI后神经病理性疼痛的镇痛机制研究进展[J].中华中医药杂志，2021， 36（6）：3483-3487.
[27] 刘兴星.针刺对佐剂性关节炎小鼠趋化因子的影响及脊髓CCL7介导针刺镇痛作用的研究[D].天津：天津中医药大学，2021.
[28] 苑功名.针刺通过脊髓BDNF-TrkB信号通路抑制NF- κB激活改善CFA小鼠炎性痛的实验研究[D].天津：天津中医药大学，2021.
[29] 胡奇妙，刘伯宇，台燕等.电针对复杂区域疼痛综合征Ⅰ型大鼠模型痛觉敏化及脊髓胶质细胞活化的影响[J].中华中医药杂志，2019，34（5）：2112-2116.
[30] Ma K，Zhu D，Zhang C，et al. Botulinum Toxin Type A Possibly Affects Ca（v）3.2 Calcium Channel Subunit in Rats with Spinal Cord Injury-Induced Muscle Spasticity [J]. Drug Des Devel Ther，2020，14：3029-3041.
[31] Palazón-García R，Benavente-Valdepe?觡as AM. Botulinum Toxin：From Poison to Possible Treatment for Spasticity in Spinal Cord Injury [J]. Int J Mol Sci，2021，22（9）：4886.
[32] Palazón-García R，Alcobendas-Maestro M，Esclarin-de Ruz A，et al.Treatment of spasticity in spinal cord injury with botulinum toxin[J]. J Spinal Cord Med，2019，42（3）：281- 287.
[33] Luvisetto S. Botulinum Toxin and Neuronal Regeneration after Traumatic Injury of Central and Peripheral Nervous System [J]. Toxins （Basel），2020，12（7）：434.
[34] de Sousa N，Santos D，Monteiro S，et al. Role of Baclofen in Modulating Spasticity and Neuroprotection in Spinal Cord Injury [J]. J Neurotrauma，2022，39（3/4）：249-258.
[35] Kumru H，Benito-Penalva J，Kofler M，et al. Analgesic effect of intrathecal baclofen bolus on neuropathic pain in spinal cord injury patients [J]. Brain Res Bull，2018，140：205-211.
京公网安备 11010502046598号